BioGeneration Ventures B.V. is a venture capital firm specializing in academic spinouts, seed capital, growth capital, and early stage investments including series A and series B rounds. The firm seeks to invest in the next generation of life sciences companies with a focus on healthcare, immuno-oncology, heart disease drugs, therapeutics, medical devices, diagnostics, novel food applications, pharmaceutical, food, agriculture and industrial biotechnology. It prefers to invest in companies based in Europe with a focus on Benelux, Netherlands, Belgium, and Germany. It prefers to invest between EUR5 million and EUR6 million. It is an active shareholder and board member in its portfolio companies. It exits its investment within 5-7 years. BioGeneration Ventures B.V. was founded in 2006 and is based in Naarden, Netherlands.